Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sarah E. Maggio"'
Publikováno v:
Drug Alcohol Depend
Background As alcohol and nicotine use disorders are entwined, it may be possible to develop a single medication to treat both. We previously developed a model for ethanol (EtOH) and nicotine co-use in female selectively bred alcohol-preferring (P) r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e2459b23f31a220ca2d873fac3baa49
https://europepmc.org/articles/PMC7293937/
https://europepmc.org/articles/PMC7293937/
Autor:
Cassie M. Chandler, Usman Hamid, Sarah E. Maggio, Hui Peng, James R. Pauly, Joshua Beckmann, Kimberly Nixon, Michael T. Bardo
Publikováno v:
Drug Alcohol Depend
BACKGROUND: Preclinical models simulating adolescent substance use leading to increased vulnerability for substance use disorders in adulthood are needed. Here, we utilized a model of alcohol and nicotine co-use to assess adult addiction vulnerabilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e65ec943cded303a6c4d0556e50862f
https://doi.org/10.1016/j.drugalcdep.2022.109298
https://doi.org/10.1016/j.drugalcdep.2022.109298
Autor:
Michael T. Bardo, Peter A. Crooks, Kimberly Nixon, Linda P. Dwoskin, Richard L. Bell, Sarah E. Maggio, Guangrong Zheng, Meredith A. Saunders, Mark A. Prendergast
Publikováno v:
Drug and Alcohol Dependence. 193:154-161
Background Although pharmacotherapies are available for alcohol (EtOH) or tobacco use disorders individually, it may be possible to develop a single pharmacotherapy to treat heavy drinking tobacco smokers by capitalizing on the commonalities in their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::636dcc72d924d3927b56c9fb0e3c6cf8
https://doi.org/10.1016/j.drugalcdep.2018.09.008
https://doi.org/10.1016/j.drugalcdep.2018.09.008
Autor:
Sarah E. Maggio, C.E. Van Skike, Anna R. Reynolds, Linda P. Dwoskin, Kimberly Nixon, Michael T. Bardo, E.M. Casey, Mark A. Prendergast
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 65:269-287
Polysubstance abuse of alcohol and nicotine has been overlooked in our understanding of the neurobiology of addiction and especially in the development of novel therapeutics for its treatment. Estimates show that as many as 92% of people with alcohol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a9ad7a0e7f4166feba941ec85857cac
https://doi.org/10.1016/j.pnpbp.2015.11.004
https://doi.org/10.1016/j.pnpbp.2015.11.004
Autor:
Richard L. Bell, Mark A. Prendergast, Linda P. Dwoskin, Meredith A. Saunders, Guangrong Zheng, Sarah E. Maggio, Thomas A. Baxter, Michael T. Bardo, Kimberly Nixon, Peter A. Crooks, Amy Hauck Newman, Rachel D. Slack
RATIONALE: Co-users of alcohol and nicotine are the largest group of polysubstance users worldwide. Commonalities in mechanisms of action for ethanol (EtOH) and nicotine proposes the possibility of developing a single pharmacotherapeutic to treat co-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04f9c8ce5cd68081d135acef02653103
https://europepmc.org/articles/PMC6058964/
https://europepmc.org/articles/PMC6058964/